197 related articles for article (PubMed ID: 21279692)
1. Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities.
Brugaletta S; Costa JR; Garcia-Garcia HM
Int J Cardiovasc Imaging; 2011 Feb; 27(2):239-48. PubMed ID: 21279692
[TBL] [Abstract][Full Text] [Related]
2. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
3. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
Hideo-Kajita A; Garcia-Garcia HM; Haude M; Joner M; Koolen J; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Teik LS; Escaned J; Azizi V; Kuku KO; Ozaki Y; Dan K; Waksman R
Cardiovasc Revasc Med; 2019 May; 20(5):392-398. PubMed ID: 31079817
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
Brugaletta S; Garcia-Garcia HM; Garg S; Gomez-Lara J; Diletti R; Onuma Y; van Geuns RJ; McClean D; Dudek D; Thuesen L; Chevalier B; Windecker S; Whitbourn R; Dorange C; Miquel-Hebert K; Sudhir K; Ormiston JA; Serruys PW
Int J Cardiovasc Imaging; 2011 Jul; 27(6):859-66. PubMed ID: 20941544
[TBL] [Abstract][Full Text] [Related]
5. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
[TBL] [Abstract][Full Text] [Related]
6. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
[TBL] [Abstract][Full Text] [Related]
7. Optimization of stent deployment by intravascular ultrasound.
Yoon HJ; Hur SH
Korean J Intern Med; 2012 Mar; 27(1):30-8. PubMed ID: 22403496
[TBL] [Abstract][Full Text] [Related]
8. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study.
Shin ES; Garcia-Garcia HM; Garg S; Ligthart J; Thuesen L; Dudek D; Ormiston JA; Serruys PW
Int J Cardiovasc Imaging; 2011 Oct; 27(7):931-7. PubMed ID: 21080074
[TBL] [Abstract][Full Text] [Related]
10. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
11. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
[No Abstract] [Full Text] [Related]
12. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
13. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
15. Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.
García-García HM; Gonzalo N; Pawar R; Kukreja N; Dudek D; Thuesen L; Ormiston JA; Regar E; Serruys PW
EuroIntervention; 2009 Jan; 4(4):443-8. PubMed ID: 19284065
[TBL] [Abstract][Full Text] [Related]
16. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.
McCutcheon K; Bennett J; Marynissen T; Adriaenssens T
Acta Cardiol; 2020 Feb; 75(1):85-86. PubMed ID: 30735472
[No Abstract] [Full Text] [Related]
17. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound.
Mintz GS
Am J Cardiol; 2007 Oct; 100(8B):26M-35M. PubMed ID: 17950829
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.
Zeng Y; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Abdelghani M; Jonker H; Digne F; Horstkotte D; Zehender M; Indolfi C; Saia F; Fiorilli R; Chevalier B; Bolognese L; Goicolea J; Nie S; Onuma Y; Serruys PW;
Int J Cardiovasc Imaging; 2017 Apr; 33(4):441-449. PubMed ID: 28012050
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of Shin's method for necrotic core and calcium content in atherosclerotic coronary lesions treated with bioresorbable everolimus-eluting vascular scaffolds using volumetric intravascular ultrasound radiofrequency-based analysis.
Shin ES; Garcia-Garcia HM; Sarno G; Thuesen L; Dudek D; Ormiston JA; Serruys PW
Int J Cardiovasc Imaging; 2012 Jan; 28(1):43-9. PubMed ID: 21229393
[TBL] [Abstract][Full Text] [Related]
20. Provisional hybrid 2-stent Strategy utilizing bioresorbable vascular scaffold and drug-eluting metal stent: "T-stenting and small protrusion" technique.
Miyazaki T; Latib A; Colombo A
Catheter Cardiovasc Interv; 2015 Oct; 86(4):682-5. PubMed ID: 25510349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
